Trump and Fox News Are Suddenly Silent on Their “Miracle” Drug Hydroxychloroquine

Their reckless promotion flew in the face of expert warnings.

Yuri Gripas/ZUMA

The coronavirus is a rapidly developing news story, so some of the content in this article might be out of date. Check out our most recent coverage of the coronavirus crisis, and subscribe to the Mother Jones Daily newsletter.

After aggressively promoting an anti-malaria drug as a “miracle” in the fight against COVID-19—a push that flew in the face of repeated warnings from experts—President Donald Trump and Fox News personalities suddenly appear to be cooling on hydroxychloroquine just as a new study reports the drug could lead to a higher death rate.

“The fact of the matter is we don’t know,” Dr. Mehmet Oz told the hosts of Fox & Friends on Wednesday. “Thankfully these medications are prescriptions only… We are better off waiting for the randomized trials Dr. Fauci has been asking for.” 

The segment was a head-spinning reversal for Oz, who less than a week ago encouraged Americans to participate in an at-home hydroxychloroquine clinical trial. “They mail you the pills, you start the protocol, tell them what happened… Be part of the solution,” he told Fox News viewers in a segment on April 16, the latest in Oz’s ongoing promotion of hydroxychloroquine on the conservative news network.

The attempt to strike a more cautious approach this week comes on the heels of new studies that showed hydroxychloroquine yielded no benefit in helping patients infected with the virus; one study on US veterans reported more deaths among those treated with the drug than those who received normal care. 

When asked about the veterans’ study on Tuesday, Trump, perhaps the biggest hydroxychloroquine cheerleader of all, dodged.

“I don’t know of the report,” he said at his daily coronavirus briefing. “Obviously there have been some very good reports and perhaps this one’s not a good report. But we’ll be looking at it.”

The claim of ignorance appeared to track with what could be a retreat in Trump’s relentless hydroxychloroquine promotion. Politico reports that the president has significantly reduced his mentions of the drug in recent days, both in his coronavirus pressers and social media, as he shifts his focus to promoting open rebellion of Democratic governors over lockdown restrictions. Still, his repeated claims that hydroxychloroquine could be a “miracle” are unlikely to be forgotten.

WE'LL BE BLUNT:

We need to start raising significantly more in donations from our online community of readers, especially from those who read Mother Jones regularly but have never decided to pitch in because you figured others always will. We also need long-time and new donors, everyone, to keep showing up for us.

In "It's Not a Crisis. This Is the New Normal," we explain, as matter-of-factly as we can, what exactly our finances look like, how brutal it is to sustain quality journalism right now, what makes Mother Jones different than most of the news out there, and why support from readers is the only thing that keeps us going. Despite the challenges, we're optimistic we can increase the share of online readers who decide to donate—starting with hitting an ambitious $300,000 goal in just three weeks to make sure we can finish our fiscal year break-even in the coming months.

Please learn more about how Mother Jones works and our 47-year history of doing nonprofit journalism that you don't find elsewhere—and help us do it with a donation if you can. We've already cut expenses and hitting our online goal is critical right now.

payment methods

WE'LL BE BLUNT

We need to start raising significantly more in donations from our online community of readers, especially from those who read Mother Jones regularly but have never decided to pitch in because you figured others always will. We also need long-time and new donors, everyone, to keep showing up for us.

In "It's Not a Crisis. This Is the New Normal," we explain, as matter-of-factly as we can, what exactly our finances look like, how brutal it is to sustain quality journalism right now, what makes Mother Jones different than most of the news out there, and why support from readers is the only thing that keeps us going. Despite the challenges, we're optimistic we can increase the share of online readers who decide to donate—starting with hitting an ambitious $300,000 goal in just three weeks to make sure we can finish our fiscal year break-even in the coming months.

Please learn more about how Mother Jones works and our 47-year history of doing nonprofit journalism that you don't elsewhere—and help us do it with a donation if you can. We've already cut expenses and hitting our online goal is critical right now.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate